Johnson & Johnson (JNJ) Financial Statements

Johnson & Johnson (JNJ) files with the U.S. Securities and Exchange Commission under CIK 0000200406. 10KGenie shows its annual and quarterly statements from SEC filings.

Key Figures, Fiscal Year 2025

Revenue
$94.19 billion
Net Income
$26.80 billion
Total Assets
$199.21 billion
Net Cash from Operations
$24.53 billion

Fiscal year ended Dec 28, 2025. Latest periodic SEC filing: Jul 23, 2026. Source: SEC filings (EDGAR XBRL).

Open the full financial statements for JNJ in 10KGenie

Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History